Author(s): Mohammad Intakhab Alam, Syam Mohan, Mohammad Ashafaq, Yosif Almoshari, Hafiz A. Makeen, Sohail Hussain

Email(s): mialam@jazanu.edu.sa , smohan@jazanu.edu.sa , mashfaqisha@jazanu.edu.sa , yalmoshari@jazanu.edu.sa , hafiz@jazanu.edu.sa , shussainamu@gmail.com

DOI: 10.52711/0974-360X.2024.00764

Address: Mohammad Intakhab Alam1, Syam Mohan2,3, Mohammad Ashafaq4, Yosif Almoshari1, Hafiz A. Makeen5, Sohail Hussain4*
1Department of Pharmaceutics, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
2Substance Abuse and Toxicology Research Centre, Jazan University, Jazan, Saudi Arabia.
3School of Health Sciences, University of Petroleum and Energy Studies, Dehradun, Uttarakhand, India.
4Department of Pharmacology and Toxicology, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
5Department of Clinical Pharmacy, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.
*Corresponding Author,

Published In:   Volume - 17,      Issue - 10,     Year - 2024


Cite this article:
Mohammad Intakhab Alam, Syam Mohan, Mohammad Ashafaq, Yosif Almoshari, Hafiz A. Makeen, Sohail Hussain. Determining the anticancer effect of Gefitinib-loaded NLCs through investigating the inflammatory cytokine (JAK-STAT) pathway. Research Journal of Pharmacy and Technology. 2024; 17(10):4968-4. doi: 10.52711/0974-360X.2024.00764




Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available